- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Neuland Labs has announced key outcomes from its recent board meeting. The company approved its consolidated financial results for the quarter ended June 30, 2025. Revenue from operations stood at ₹294.75 Cr, with a net profit of ₹13.90 Cr for the quarter. EPS for the period was ₹10.83. Additionally, the Board has re-appointed Dr. Ravi Shankar Gopinath as an Independent Additional Director for a five-year term, effective August 1, 2025, pending shareholder approval. This move aims to leverage his extensive global experience.